HEALTH● LOWJul 30 · Jul 30, 2026, 6:55 PM
Wave outlines WVE-007 Phase IIa in BMI 35-50 obesity, while projecting cash runway into Q3 2028
Seeking Alpha Tech
Wave has provided details on its WVE-007 Phase IIa trial for obesity in patients with a BMI of 35-50. The company projects its cash reserves to extend into the third quarter of 2028.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH1h agoEbola: NCDC tracks 53 contacts, orders hospitals to isolate suspectsVanguard NigeriaHEALTH1h agoNCDC approves N100,000 weekly stipend for Ebola contactsVanguard NigeriaHEALTH1h agoEbola: 53 Contacts, Including Healthcare Workers Under Surveillance, Says NCDCChannels TVHEALTH1h agoAstraZeneca stomach cancer drug doubles survival in late-stage trialSeeking Alpha Tech